Insilico Medicine's Inhaled Solution Receives Clinical Trial Approval from China's CDE
Insilico Medicine recently announced that its drug candidate, Rentosertib Inhalation Solution, has r...
Samsung Bioepis Partners with ATLATL to Accelerate Biotech Incubation in Asia-Pacific
Samsung Bioepis Co., Ltd. and ATLATL Innovation Center recently announced the signing of a Memorandu...
India's Sun Pharma to Acquire Organon for $11.75 Billion
India's Sun Pharmaceutical Industries Ltd. announced it will acquire U.S.-based Organon in an all-ca...
U.S. Serif Launches Modified DNA Therapy with $50M Funding from Flagship Pioneering
U.S. startup Serif Biomedicines has recently emerged from stealth mode, introducing a novel therapeu...
Samsung Bioepis and ATLATL Collaborate to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
Samsung Bioepis Co., Ltd. and ATLATL Innovation Centre, a global life science R&D innovation platfor...
Clinical Trial Pharmacy Software Drives Digital Transformation in Drug Development
The pharmaceutical and biotechnology industry is undergoing a major transformation in clinical trial...
Solengepras improves non-motor symptoms in Parkinson's disease
Solengepras has shown early potential in treating Parkinson's disease (PD), particularly targeting o...
IMG Pharma Acquires Japan's Matsumoto Pharmaceutical to Strengthen Integrated Healthcare Platform
IMG Pharma Co., Ltd. (IMG Pharma), based in Tokyo, Japan, announced that it has reached a definitive...
Xcovery Partners with EVERSANA to Expand Launch of ALK-Positive Lung Cancer Drug
Xcovery Holdings has entered into a collaboration agreement with commercialization services provider...
BD and Suttons Creek Partner to Advance Combination Product Development
Becton, Dickinson and Company (BD) and Suttons Creek, a BlueRidge Life Sciences company, have announ...